AU3524799A - A method for monitoring the tolerability of levosimendan administration - Google Patents

A method for monitoring the tolerability of levosimendan administration

Info

Publication number
AU3524799A
AU3524799A AU35247/99A AU3524799A AU3524799A AU 3524799 A AU3524799 A AU 3524799A AU 35247/99 A AU35247/99 A AU 35247/99A AU 3524799 A AU3524799 A AU 3524799A AU 3524799 A AU3524799 A AU 3524799A
Authority
AU
Australia
Prior art keywords
tolerability
monitoring
levosimendan
administration
levosimendan administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35247/99A
Other languages
English (en)
Inventor
Aira Heikkila
Lasse Lehtonen
Timo Lotta
Hanna Nikkanen
Pekka Ottoila
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Oyj filed Critical Orion Oyj
Publication of AU3524799A publication Critical patent/AU3524799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9453—Cardioregulators, e.g. antihypotensives, antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU35247/99A 1998-04-23 1999-04-23 A method for monitoring the tolerability of levosimendan administration Abandoned AU3524799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI980903 1998-04-23
FI980903A FI105389B (fi) 1998-04-23 1998-04-23 Menetelmä levosimendaaniannon siedettävyyden seuraamiseksi
PCT/FI1999/000330 WO1999056134A1 (fr) 1998-04-23 1999-04-23 Procede pour surveiller la tolerance a l'administration de levosimendane

Publications (1)

Publication Number Publication Date
AU3524799A true AU3524799A (en) 1999-11-16

Family

ID=8551577

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35247/99A Abandoned AU3524799A (en) 1998-04-23 1999-04-23 A method for monitoring the tolerability of levosimendan administration

Country Status (3)

Country Link
AU (1) AU3524799A (fr)
FI (1) FI105389B (fr)
WO (1) WO1999056134A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020408323A1 (en) 2019-12-16 2022-08-11 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HF-pEF)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8903130D0 (en) * 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB9606474D0 (en) * 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan

Also Published As

Publication number Publication date
FI105389B (fi) 2000-08-15
WO1999056134A1 (fr) 1999-11-04
FI980903A (fi) 1999-10-24
FI980903A0 (fi) 1998-04-23

Similar Documents

Publication Publication Date Title
EP1093955A3 (fr) Procédé pour adapter automatiquement l'affichage d'un instrument combiné
AU3995599A (en) Compliance monitoring system
AU5732699A (en) Corneal onlay
AU6275399A (en) Perilaryngeal oral airway
AU3790700A (en) Intraluminal monitoring system
AU1513400A (en) A foaming tablet for cleaning the oral cavity and preparation method thereof
AU2223197A (en) A nebuliser
AU5198298A (en) Acidic bleaching solution, method of preparation and a bleaching system for forming the same
AU7902400A (en) Method for the preparation of 5-carboxyphthalide
AU3250499A (en) A wheelchair
AU5065999A (en) Naphthyridine derivatives
AU6105199A (en) Diagnostic method
AU5737498A (en) Method for the preparation of alpha-bromo-lactam derivatives
AU4335197A (en) Technique for manufacturing hose
AU3606899A (en) Equipment for changing a dialysate
AU2150600A (en) System and method for providing a dental diagnosis
AU1581100A (en) Method and apparatus for managing the configuration and functionality of a semiconductor design
AU1694501A (en) Method for producing a medicament
AU3524799A (en) A method for monitoring the tolerability of levosimendan administration
AU1130901A (en) Method for the preparation of 5-carboxyphthalide
AU4506199A (en) Method for calculating the variance
AU4821899A (en) A process for the preparation of macrocyclic metalloprotease inhibitors
AU4707599A (en) Denture system
AUPP612798A0 (en) Diagnostic method
AU1984900A (en) Diagnostic method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase